TINKESO THERAPEUTICS, INC. ANNOUNCES THE ACCEPTANCE BY INDIEBIO NYC TO ITS 2024 FALL STARTUP DEVELOPMENT PROGRAM
NKT Cell Therapy Firm Joins IndieBio Program VALHALLA, NY, UNITED STATES, September 5, 2024 /EINPresswire.com/ -- Tinkeso Therapeutics, Inc., an early-stage biotechnology company focused on the development of allogeneic, off-the-shelf, natural killer T …